Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 3/14/2015
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Uveitis, Visual acuity reduced, Visual acuity tests abnormal, Visual field defect, Visual impairment
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Unknown
Diagnostic Lab Data: On an unknown dates, visual acuity test showed: 1.0 and 0.3 (units not provided)
CDC 'Split Type': WAES1409JPN011905
Write-up:Initial information has been received from a physician concerning a female (an adult) who on February 2013 (date unspecified) was vaccinated with HPV vaccine (manufacturer unknown) injection, route reported as parenteral, dose, injection site were not reported. No concomitant medications were reported. In February 2013 (date unspecified) the patient was vaccinated with HPV vaccine (manufacturer unknown). In February 2013 (date unspecified), a few days after vaccination, the patient felt difficulty seeing. Visual impairment developed. On an unspecified date, the patient was seen by the reporting physician (ophthalmologist). Visual field defect and visual acuity reduced (declined from 1.0 to 0.3) were observed. The patient had symptoms like uveitis. As of reporting date 22-SEP-2014, visual impairment had resolved/recovered. The patient told that the physician who performed the vaccination considered the relationship of the adverse event to the HPV vaccine (manufacturer unknown) as unknown. The reporting physician did not assess the relationship of the adverse event to HPV vaccine (manufacturer unknown). The reporting physician considered the visual impairment as serious (disability). Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166